Atai life sciences to participate in november investor events & healthcare conferences

New york and berlin, nov. 01, 2022 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following investor events & healthcare conferences:
ATAI Ratings Summary
ATAI Quant Ranking